Amedisys (AMED)
(Delayed Data from NSDQ)
$99.31 USD
+0.81 (0.82%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $99.31 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Amedisys, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Outpatient and Home Healthcare industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AMED 99.31 +0.81(0.82%)
Will AMED be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMED
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
AMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates
Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?
Other News for AMED
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors
Decoding Amedisys Inc (AMED): A Strategic SWOT Insight
Amedisys (AMED) Exceeds Q2 Revenue Expectations
Amedisys Inc Q2 2025 Earnings: Revenue Surpasses Estimates at $621. ...
Amedisys Inc (AMED) Reports Q2 2025 Financial Results | AMED stock news